Corvus Pharmaceuticals, Inc.CRVSNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, modest growth trend.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-62.29M
↓ 57% below average
Average (9y)
$-39.68M
Historical baseline
Range
High:$-6.00M
Low:$-62.29M
CAGR
+7.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-62.29M | -130.5% |
| 2023 | $-27.03M | +34.6% |
| 2022 | $-41.31M | +4.5% |
| 2021 | $-43.24M | -621.3% |
| 2020 | $-6.00M | +87.2% |
| 2019 | $-46.67M | +0.6% |
| 2018 | $-46.94M | +15.7% |
| 2017 | $-55.66M | -53.0% |
| 2016 | $-36.38M | -16.1% |
| 2015 | $-31.34M | - |